Metalmark Capital up to $50 million investment in Morgenesis
We advised Metalmark on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Molded Devices acquisition of GlobalMed and Schauenburg-Truplast
We advised Molded Devices on the acquisition and the related financing arrangements
Johnson & Johnson $16.6 billion acquisition of Abiomed
We are advising J.P. Morgan Securities as financial adviser to Johnson & Johnson
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction
Freeman Spogli investment in EverVet
We advised Tailwind Capital and EverVet on the transaction
Esco Aster spinoff transactions
We are advising Esco Lifesciences on the spinoff
InSilico Medicine $35 million Series D2 financing
We are advising InSilico Medicine on the financing
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
Taibang Biologic Group $300 million equity raising
We are advising Taibang Biologic Group in connection with its equity raising by a group of investors